[{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Chairperson","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Lisa M. Coussens<\/i><\/u><\/presenter>. OHSU Knight Cancer Institute, Portland, OR","CSlideId":"","ControlKey":"cd0e27a8-791b-4c89-b8d2-ebb7523ed20c","ControlNumber":"10320","DisclosureBlock":"&nbsp;<b>&nbsp;L.M. Coussens:<\/b>  ; AbbVie Inc.. ; Alkermes, Inc.. ; American Association for Cancer Research. ; AstraZeneca AB. ; Bloomberg-Kimmel Institute for Cancer Immunotherarpy. ; Cancer Research Institute. ; Carisma Therapeutics Inc.. ; Cell Signaling Technologies. ; Columbia University Medical Center. ; CytomX Therapeutics Inc.. ; Dana Farber Cancer Center Breast SPORE. ; Dana Farber\/Harvard Cancer Center. ; Genenta Sciences. ; Hibercell, Inc.. ; Kineta Inc.. ; Koch Institute for Integrated Cancer Research. ; Lustgarten Foundation. ; MDACC GI SPORE. ; NIH\/NCI-Frederick National Laboratory Advisory Committee. ; National Foundation for Cancer Research. ; NextCure. ; PDX Pharmaceuticals, Inc.. ; Pio Therapeutics Pty Ltd. ; Prospect Creek Foundation. ; Shasqi, Inc.. ; Susan G. Komen. ; Susan G. Komen Foundation, Komen Scholar. ; Syndax Pharmaceuticals Inc.. ; The Jackson Laboratory Cancer Center. ; University of California, San Diego Moores Cancer Center. ; Zymeworks, Inc..","End":"4\/17\/2023 4:46:00 PM","HasWebcast":null,"Highlights":[],"Id":"9096","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"1","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Lisa Coussens, PhD","PresenterKey":"28b4c13f-457b-4975-a458-3416b7fce36c","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Chairperson","SearchResultFooter":"","SearchResultHeader":"Apr 17 2023  4:45PM","SessionId":"610","SessionOnDemand":"False","SessionTitle":"AACR-ASCO Joint Session: Myeloid-targeted Agents for Solid Tumors","ShowChatLink":"false","Start":"4\/17\/2023 4:45:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Chairperson","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Chairperson","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Eric P. Winer<\/i><\/u><\/presenter>. Yale University, New Haven, CT","CSlideId":"","ControlKey":"e72d1618-7643-4ece-96c6-1a581d619f1f","ControlNumber":"10321","DisclosureBlock":"","End":"4\/17\/2023 4:46:00 PM","HasWebcast":null,"Highlights":[],"Id":"9097","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"2","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Eric Winer, MD","PresenterKey":"8164cc04-e220-415f-a63f-4caa8d656a99","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Chairperson","SearchResultFooter":"","SearchResultHeader":"Apr 17 2023  4:45PM","SessionId":"610","SessionOnDemand":"False","SessionTitle":"AACR-ASCO Joint Session: Myeloid-targeted Agents for Solid Tumors","ShowChatLink":"false","Start":"4\/17\/2023 4:45:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Chairperson","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Lisa M. Coussens<\/i><\/u><\/presenter>. OHSU Knight Cancer Institute, Portland, OR","CSlideId":"","ControlKey":"4d46ab19-6a23-48e8-bacc-fa1e96af3749","ControlNumber":"10903","DisclosureBlock":"<b>&nbsp;L. M. Coussens, <\/b> <br><b>AbbVie Inc.<\/b> I, I, I, I. <br><b>Alkermes, Inc.<\/b> I, I, I, I. <br><b>American Association for Cancer Research<\/b> I, I, I, I. <br><b>AstraZeneca AB<\/b> I, I, I, I. <br><b>Bloomberg-Kimmel Institute for Cancer Immunotherarpy<\/b> I, I, I, I. <br><b>Cancer Research Institute<\/b> I, I, I, I. <br><b>Carisma Therapeutics Inc.<\/b> I, I, I, I. <br><b>Cell Signaling Technologies<\/b> I, I, I, I. <br><b>Columbia University Medical Center<\/b> I, I, I, I. <br><b>CytomX Therapeutics Inc.<\/b> I, I, I, I. <br><b>Dana Farber Cancer Center Breast SPORE<\/b> I, I, I, I. <br><b>Dana Farber\/Harvard Cancer Center<\/b> I, I, I, I. <br><b>Genenta Sciences<\/b> I, I, I, I. <br><b>Hibercell, Inc.<\/b> I, G, I, G, I, G, I, G. <br><b>Kineta Inc.<\/b> I, I, I, I. <br><b>Koch Institute for Integrated Cancer Research<\/b> I, I, I, I. <br><b>Lustgarten Foundation<\/b> I, G, I, G, I, G, I, G. <br><b>MDACC GI SPORE<\/b> I, I, I, I. <br><b>NIH\/NCI-Frederick National Laboratory Advisory Committee<\/b> I, I, I, I. <br><b>National Foundation for Cancer Research<\/b> G, G, G, G. <br><b>NextCure<\/b> I, I, I, I. <br><b>PDX Pharmaceuticals, Inc.<\/b> I, I, I, I. <br><b>Pio Therapeutics Pty Ltd<\/b> I, I, I, I. <br><b>Prospect Creek Foundation<\/b> G, G, G, G. <br><b>Shasqi, Inc.<\/b> I, I, I, I. <br><b>Susan G. Komen<\/b> G, G, G, G. <br><b>Susan G. Komen Foundation, Komen Scholar<\/b> I, I, I, I. <br><b>Syndax Pharmaceuticals Inc.<\/b> G, G, G, G. <br><b>The Jackson Laboratory Cancer Center<\/b> I, I, I, I. <br><b>University of California, San Diego Moores Cancer Center<\/b> I, I, I, I. <br><b>Zymeworks, Inc.<\/b> I, I, I, I.","End":"4\/17\/2023 4:48:00 PM","HasWebcast":null,"Highlights":[],"Id":"10676","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"3","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Lisa Coussens, PhD","PresenterKey":"28b4c13f-457b-4975-a458-3416b7fce36c","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Welcome and introductory remarks from the AACR President","SearchResultFooter":"","SearchResultHeader":"Apr 17 2023  4:45PM","SessionId":"610","SessionOnDemand":"False","SessionTitle":"AACR-ASCO Joint Session: Myeloid-targeted Agents for Solid Tumors","ShowChatLink":"false","Start":"4\/17\/2023 4:45:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Welcome and introductory remarks from the AACR President","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Eric P. Winer<\/i><\/u><\/presenter>. Yale University, New Haven, CT","CSlideId":"","ControlKey":"da29bf5a-8d60-48c0-82b5-8fe113dc2eaa","ControlNumber":"10904","DisclosureBlock":"","End":"4\/17\/2023 4:50:00 PM","HasWebcast":null,"Highlights":[],"Id":"10677","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"4","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Eric Winer, MD","PresenterKey":"8164cc04-e220-415f-a63f-4caa8d656a99","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Welcome and introductory remarks from the ASCO President","SearchResultFooter":"","SearchResultHeader":"Apr 17 2023  4:45PM","SessionId":"610","SessionOnDemand":"False","SessionTitle":"AACR-ASCO Joint Session: Myeloid-targeted Agents for Solid Tumors","ShowChatLink":"false","Start":"4\/17\/2023 4:48:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Welcome and introductory remarks from the ASCO President","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Karin E. De Visser<\/i><\/u><\/presenter>. Netherlands Cancer Institute, Amsterdam, Netherlands","CSlideId":"","ControlKey":"e08a8a71-b7b8-4f5d-9d12-c1817dcf89d0","ControlNumber":"10792","DisclosureBlock":"<b>&nbsp;K. E. de Visser, <\/b> <br><b>F. Hoffmann-La Roche<\/b> G, G, G. <br><b>macomics<\/b> I, I, I.","End":"4\/17\/2023 5:12:00 PM","HasWebcast":null,"Highlights":[],"Id":"10554","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"5","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Karin de Visser, PhD","PresenterKey":"71820c5d-8973-49db-a54a-80b35f7e42d2","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Eosinophils as emerging players in immune checkpoint blockade in advanced breast cancer: Mechanisms and potential clinical implications","SearchResultFooter":"","SearchResultHeader":"Apr 17 2023  4:45PM","SessionId":"610","SessionOnDemand":"False","SessionTitle":"AACR-ASCO Joint Session: Myeloid-targeted Agents for Solid Tumors","ShowChatLink":"false","Start":"4\/17\/2023 4:50:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Eosinophils as emerging players in immune checkpoint blockade in advanced breast cancer: Mechanisms and potential clinical implications","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"8c7b399e-346b-496d-8d72-17b6004b1dfc","ControlNumber":"11025","DisclosureBlock":"","End":"4\/17\/2023 5:17:00 PM","HasWebcast":null,"Highlights":[],"Id":"10803","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"6","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr 17 2023  4:45PM","SessionId":"610","SessionOnDemand":"False","SessionTitle":"AACR-ASCO Joint Session: Myeloid-targeted Agents for Solid Tumors","ShowChatLink":"false","Start":"4\/17\/2023 5:12:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Padmanee Sharma<\/i><\/u><\/presenter>. UT MD Anderson Cancer Center, Houston, TX","CSlideId":"","ControlKey":"dbcc8d3e-f161-4256-9fd0-f12085862d5f","ControlNumber":"10319","DisclosureBlock":"<b>&nbsp;P. Sharma, <\/b> <br><b>Achelois Pharmaceuticals<\/b> I, I, I, I. <br><b>Adaptive Biotechnologies Corporation<\/b> I, I, I, I. <br><b>Affini-T<\/b> I, I, I, I. <br><b>Apricity<\/b> I, I, I, I. <br><b>AsherBio<\/b> I, I, I, I. <br><b>BioAlta LLC<\/b> I, I, I, I. <br><b>BioNTech<\/b> I, I, I, I. <br><b>C-Reveal Therapeutics<\/b> I, I, I, I. <br><b>Candel Therapeutics<\/b> I, I, I, I. <br><b>Carisma<\/b> I, I, I, I. <br><b>Catalio Capital Management<\/b> I, I, I, I. <br><b>Codiak Biosciences, Inc<\/b> I, I, I, I. <br><b>Dragonfly Therapeutics, formerly called  Equipoise Therapeutics Corporation<\/b> I, I, I, I. <br><b>Earli Inc.<\/b> I, I, I, I. <br><b>Enable Medicine<\/b> I, I, I, I. <br><b>Glympse Bio<\/b> I, I, I, I. <br><b>Hengenix<\/b> I, I, I, I. <br><b>Hummingbird Bioscience<\/b> I, I, I, I. <br><b>ImaginAb<\/b> I, I, I, I. <br><b>Infinity Pharmaceuticals Inc.<\/b> I, I, I, I. <br><b>InterVenn Biosciences<\/b> I, I, I, I. <br><b>JSL Health<\/b> I, I, I, I. <br><b>LAVA Therapeutics<\/b> I, I, I, I. <br><b>Lytix Biopharma<\/b> I, I, I, I. <br><b>Marker Therapeutics<\/b> I, I, I, I. <br><b>Oncolytics Biotech<\/b> I, I, I, I. <br><b>PBM Capital<\/b> I, I, I, I. <br><b>Phenomic AI<\/b> I, I, I, I. <br><b>Polaris Pharma<\/b> I, I, I, I. <br><b>Sporos<\/b> I, I, I, I. <br><b>Time Bioventures<\/b> I, I, I, I. <br><b>Trained Therapeutix Discovery<\/b> I, I, I, I. <br><b>Two Bear Capital<\/b> I, I, I, I. <br><b>Xilis, Inc<\/b> I, I, I, I.","End":"4\/17\/2023 5:39:00 PM","HasWebcast":null,"Highlights":[],"Id":"9095","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"7","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Padmanee Sharma, MD;PhD","PresenterKey":"6ed707ff-ed42-431c-a173-4ce5a6ff2138","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"From the clinic to the lab: Investigating myeloid cells that drive resistance to immune checkpoint therapy","SearchResultFooter":"","SearchResultHeader":"Apr 17 2023  4:45PM","SessionId":"610","SessionOnDemand":"False","SessionTitle":"AACR-ASCO Joint Session: Myeloid-targeted Agents for Solid Tumors","ShowChatLink":"false","Start":"4\/17\/2023 5:17:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"From the clinic to the lab: Investigating myeloid cells that drive resistance to immune checkpoint therapy","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"86ccdcef-2adb-4e7d-9833-479267325e26","ControlNumber":"11026","DisclosureBlock":"","End":"4\/17\/2023 5:44:00 PM","HasWebcast":null,"Highlights":[],"Id":"10804","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"8","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr 17 2023  4:45PM","SessionId":"610","SessionOnDemand":"False","SessionTitle":"AACR-ASCO Joint Session: Myeloid-targeted Agents for Solid Tumors","ShowChatLink":"false","Start":"4\/17\/2023 5:39:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Invited Speaker","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":"<presenter><u><i>Paulo C. Rodriguez<\/i><\/u><\/presenter>. Moffitt Cancer Center, Tampa, FL","CSlideId":"","ControlKey":"b161ce0b-e38d-4938-9e8a-f73595bcdd9c","ControlNumber":"11034","DisclosureBlock":"&nbsp;<b>P. C. Rodriguez, <\/b> None.","End":"4\/17\/2023 6:06:00 PM","HasWebcast":null,"Highlights":[],"Id":"10812","IsPresentation":"True","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"9","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":"Paulo Rodriguez, PhD","PresenterKey":"0c611870-b292-40db-904b-8cd8bc819e81","PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Reprogramming of immunosuppressive myeloid cells in tumors through modulation of stress responses","SearchResultFooter":"","SearchResultHeader":"Apr 17 2023  4:45PM","SessionId":"610","SessionOnDemand":"False","SessionTitle":"AACR-ASCO Joint Session: Myeloid-targeted Agents for Solid Tumors","ShowChatLink":"false","Start":"4\/17\/2023 5:44:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Reprogramming of immunosuppressive myeloid cells in tumors through modulation of stress responses","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"9a934340-7970-4359-bcab-3921e3f4d889","ControlNumber":"11027","DisclosureBlock":"","End":"4\/17\/2023 6:11:00 PM","HasWebcast":null,"Highlights":[],"Id":"10805","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"10","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Discussion","SearchResultFooter":"","SearchResultHeader":"Apr 17 2023  4:45PM","SessionId":"610","SessionOnDemand":"False","SessionTitle":"AACR-ASCO Joint Session: Myeloid-targeted Agents for Solid Tumors","ShowChatLink":"false","Start":"4\/17\/2023 6:06:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Discussion","Topics":null,"cSlideId":""},{"Abstract":"There is no abstract associated with this presentation.","Actions":[{"Icon":null,"Label":"View Abstract","SubType":null,"Type":"ViewAbstract","Url":null},{"Icon":null,"Label":"View Video","SubType":null,"Type":"ViewPlayer","Url":null},{"Icon":null,"Label":"Rating","SubType":null,"Type":"Rating","Url":null}],"Activity":"Other","AdditionalFields":[{"Key":"Topics","Value":",,"},{"Key":"Keywords","Value":",,,,"},{"Key":"ePosterClassification","Value":""},{"Key":"ePosterNote","Value":""},{"Key":"VideoType","Value":""},{"Key":"cSlidePresentationId","Value":""},{"Key":"ePosterLink","Value":""},{"Key":"WebcastProgramPlannerLink","Value":""}],"AdditionalFiles":[],"AllowAttendeeRating":"False","AttendeeRatingAvg":"0","AttendeeRatingCount":"0","AuthorBlock":". ","CSlideId":"","ControlKey":"1e79943a-c722-4e5e-8e91-6ee6ca53efcd","ControlNumber":"11028","DisclosureBlock":"","End":"4\/17\/2023 6:15:00 PM","HasWebcast":null,"Highlights":[],"Id":"10806","IsPresentation":"False","IsSessionOrganizer":"False","Keywords":null,"MediaSource":"None","OtherContent":null,"PlayerUrl":null,"PlayerUrlReason":null,"PositionInSession":"11","PosterboardNumber":"","PresentationFiles":null,"PresentationMediaItemId":null,"PresentationMediaItemKey":null,"PresentationNumber":"","PresenterBiography":null,"PresenterDisplayName":null,"PresenterKey":null,"PresenterPhoto":null,"SearchResultActions":null,"SearchResultBody":"Closing Remarks","SearchResultFooter":"","SearchResultHeader":"Apr 17 2023  4:45PM","SessionId":"610","SessionOnDemand":"False","SessionTitle":"AACR-ASCO Joint Session: Myeloid-targeted Agents for Solid Tumors","ShowChatLink":"false","Start":"4\/17\/2023 6:11:00 PM","Status":"Presenting","Tags":null,"ThumbnailUrl":null,"Title":"Closing Remarks","Topics":null,"cSlideId":""}]